跳至主要内容
临床试验/ISRCTN16769682
ISRCTN16769682进行中(未招募)Unknown

An observational, registry-based study of performance and safety data from participants treated for open angle glaucoma or ocular hypertension with the Eagle device

BELKIN Vision Ltd.0 个研究点目标入组 550 人开始时间: 2024年7月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Adult participants who underwent treatment with the Eagle device for treatment of Open Angle Glaucoma including exfoliative or pigmentary glaucoma or ocular hypertension as per the approved indication.
  • 2. Participants with expected post-operative follow-up data of at least six (6) months

排除标准

  • Records of participants with any of the following conditions at the date of the treatment with the Eagle device, will not be included in the data collection:
  • 1. Participants who are unable to fixate their head and/or eyes, such as participants suffering from nystagmus, tremors or similar conditions.
  • 2. Participants with congenital glaucoma or active anterior segment inflammations.
  • 3. Participants with any condition that obscures the limbus, such as melanosis affecting the limbus, severe arcus senilis affecting the limbus, pterygium affecting the limbus or any other such conditions.
  • 4. Participants with any condition that causes poor visualization of the limbus that prevents the Eagle device’s treatment target identification.

研究者

发起方
BELKIN Vision Ltd.

相似试验